|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.322 SEK | +1.69% |
|
+0.15% | +43.07% |
| 22/05 | Intervacc AB Completes Successful Evaluation of Us Strain of Strangles Pathogen Ahead of Clinical Trials | CI |
| 15/05 | Sweden's Intervacc Elects New Chair | MT |
| Market Cap | 45Cr 4.69Cr 4.1Cr 3.79Cr 3.54Cr 6.64Cr 443.3Cr 6.69Cr 18Cr 217.95Cr 18Cr 17Cr 757.17Cr | P/E 2026 * |
-5.51x | P/E 2027 * | -5.51x |
|---|---|---|---|---|---|
| Enterprise Value | 36Cr 3.79Cr 3.31Cr 3.06Cr 2.86Cr 5.36Cr 357.7Cr 5.4Cr 14Cr 175.87Cr 14Cr 14Cr 610.96Cr | EV / Sales 2026 * |
22.7x | EV / Sales 2027 * | 11.8x |
| Free-Float |
80.66% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +1.69% | ||
| 1 week | +0.15% | ||
| Current month | +6.61% | ||
| 1 month | +4.09% | ||
| 3 months | +35.04% | ||
| 6 months | +46.24% | ||
| Current year | +43.07% |
| 1 week | 1.28 |  | 1.35 |
| 1 month | 1.17 | | 1.38 |
| Current year | 0.57 | | 1.46 |
| 1 year | 0.57 | | 1.46 |
| 3 years | 0.57 | | 10.46 |
| 5 years | 0.57 | | 84 |
| 10 years | 0.57 | | 95.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 70 | 05/02/2026 | |
Jan Persson
DFI | Director of Finance/CFO | - | 06/02/2020 |
Andrew Waller
CTO | Chief Tech/Sci/R&D Officer | - | 11/06/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
Emil Billbäck
CHM | Chairman | 56 | 13/05/2026 |
| Director/Board Member | 72 | 01/01/2024 | |
| Director/Board Member | 68 | 01/01/2025 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 23/25/23 | Free | Chief Financial Officer | 9,29,208 | 1.2269% | ||
| 17/25/17 | Sell | Chief Executive Officer | 2,78,820 | 0.3681% | ||
| 17/25/17 | Buy | Chief Executive Officer | 1,35,000 | 0.1783% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.69% | +0.15% | +38.14% | -77.78% | 4.69Cr | |
| +0.28% | +5.53% | +71.16% | +119.60% | 5.67TCr | |
| +4.00% | +7.51% | +63.67% | +68.77% | 4.75TCr | |
| -0.77% | -0.67% | -15.34% | -15.95% | 2.28TCr | |
| +2.93% | +1.17% | -3.97% | +384.78% | 2.14TCr | |
| +0.33% | +2.60% | +25.71% | -18.41% | 1.61TCr | |
| +1.95% | +3.86% | +20.23% | -36.42% | 1.56TCr | |
| -1.08% | -3.11% | +27.20% | +158.30% | 1.29TCr | |
| +3.30% | +15.02% | +133.24% | +273.89% | 1.29TCr | |
| +0.61% | -7.10% | +20.63% | - | 1.17TCr | |
| Average | +1.32% | +1.95% | +38.07% | +95.20% | 2.17TCr | |
| Weighted average by Cap. | +1.46% | +3.27% | +44.40% | +109.80% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.6Cr 16.66L 14.56L 13.46L 12.57L 23.59L 16Cr 23.77L 62.25L 7.74Cr 62.54L 61.19L 27Cr | 3Cr 31.23L 27.29L 25.25L 23.56L 44.24L 30Cr 44.56L 1.17Cr 15Cr 1.17Cr 1.15Cr 50Cr |
| Net income | -8.16Cr -84.96L -74.24L -68.67L -64.09L -1.2Cr -80Cr -1.21Cr -3.17Cr -39Cr -3.19Cr -3.12Cr -137.13Cr | -8.33Cr -86.73L -75.78L -70.1L -65.43L -1.23Cr -82Cr -1.24Cr -3.24Cr -40Cr -3.26Cr -3.19Cr -139.99Cr |
| Net Debt | -8.7Cr -90.58L -79.15L -73.21L -68.33L -1.28Cr -86Cr -1.29Cr -3.39Cr -42Cr -3.4Cr -3.33Cr -146.21Cr | -9.6Cr -99.95L -87.34L -80.79L -75.4L -1.42Cr -94Cr -1.43Cr -3.74Cr -46Cr -3.75Cr -3.67Cr -161.33Cr |
Employees
16
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 22/26/22 | 1.322 kr | +1.69% | 5,12,115 |
| 18/26/18 | 1.300 kr | -0.76% | 5,38,301 |
| 17/26/17 | 1.310 kr | -2.24% | 3,75,168 |
| 16/26/16 | 1.340 kr | +1.52% | 4,04,662 |
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- IVACC Stock
Select your edition
All financial news and data tailored to specific country editions
